Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,663 | -27,781 | -72,902 | -64,097 | -29,932 |
| Depreciation Amortization | 1,564 | 1,680 | 23,916 | 4,261 | 918 |
| Income taxes - deferred | N/A | N/A | 0 | -9,261 | -1,254 |
| Accounts receivable | -1,129 | 109 | -575 | -1,229 | -182 |
| Accounts payable and accrued liabilities | 967 | -4,757 | 297 | -1,348 | 848 |
| Other Working Capital | -1,321 | -3,971 | -1,942 | -2,203 | 1,982 |
| Other Operating Activity | 39,869 | 11,395 | 5,638 | 37,936 | 1,640 |
| Operating Cash Flow | $-20,713 | $-23,325 | $-45,568 | $-35,941 | $-25,980 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 367 | N/A | N/A | N/A |
| PPE Investments | -512 | 73 | -4,340 | -2,247 | -1,227 |
| Net Acquisitions | N/A | N/A | N/A | -11,714 | -6,514 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -4,000 |
| Other Investing Activity | 0 | -1,372 | 0 | 0 | -7 |
| Investing Cash Flow | $-512 | $-932 | $-4,340 | $-13,961 | $-11,748 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,141 |
| Debt Repayment | -201 | -117 | -1,429 | -1,534 | -446 |
| Common Stock Issued | 27,814 | 13,848 | 32,843 | 83,202 | 22,250 |
| Common Stock Repurchased | N/A | N/A | N/A | -239 | -14 |
| Other Financing Activity | -7,184 | -1,545 | 4,392 | -3,065 | -132 |
| Financing Cash Flow | $20,429 | $12,186 | $35,806 | $78,364 | $22,799 |
| Beginning Cash Position | 11,132 | 23,203 | 37,305 | 8,843 | 23,772 |
| End Cash Position | 10,336 | 11,132 | 23,203 | 37,305 | 8,843 |
| Net Cash Flow | $-796 | $-12,071 | $-14,102 | $28,462 | $-14,929 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,713 | -23,325 | -45,568 | -35,941 | -25,980 |
| Capital Expenditure | -516 | -281 | -4,340 | -2,247 | -1,227 |
| Free Cash Flow | -21,229 | -23,606 | -49,908 | -38,188 | -27,207 |